Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community. 

Our key focus areas are Cancer biology and care , Chronic disease biology and care , Implementing evidence to improve health , Mothers', babies and women's health , Neurosciences and cognitive health , Optimising acute care .

BICARE grant supports health of children with autism
Mater Researcher Dr Jake Gratten has received more than $98,000 in funding to progress research into anxiety and gastrointestinal disorders in autistic children.
“If we can understand the role of the gut microbiota in anxiety and functional gastrointestinal disorders, then there is a possibility that we can determine how to modify the gut microbiota to relieve these symptoms.”
Mater helps bring new hope to patients with cystic fibrosis
A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).
“The new drug known as VX-445, in combination with two existing treatments, has demonstrated lung function improvement of around 10 per cent–which is really significant for cystic fibrosis patients,” said Dr Burr, Mater’s Director of Cystic Fibrosis and Mater Research Institute-The University of Queensland (MRI-UQ) researcher.
Conjoint Professor of Neuroscience establishes memory clinic at Mater
Cognitive Neurologist Professor Peter Nestor was recently appointed Conjoint Professor of Neuroscience between The University of Queensland and Mater and has started his appointment by establishing a memory clinic at Mater.
The memory clinic is a multidisciplinary tertiary referral clinic, providing clinical and cognitive assessments for people with suspected degenerative brain diseases that may give rise to dementia.
Latest News

From October 2018 the new Ethics Review Manager (ERM) system will replace the Mater Research Hub to generate new applications to Mater...

19

Oct

Ethics Review Manager System roll out - Important information for researchers

A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).

19

Oct

Mater helps bring new hope to patients with cystic fibrosis

Mater Researcher Dr Jake Gratten has received more than $98,000 in funding to progress research into anxiety and gastrointestinal disorders in...

19

Oct

BICARE grant supports health of children with autism

Following an international search, Professor Maher Gandhi has been appointed Director of Clinical Research at Mater Research.

03

Oct

Mater Research announces appointment to Director of Clinical Research

Mater researchers received two prestigious awards at this year’s Women in Technology (WiT) awards ceremony held at the Royal International...

17

Sep

Mater Research recognised at 2018 Women in Technology Awards

Mater Research’s Cancer Immunotherapies Research Group have received prestigious travel awards to attend international conferences

10

Sep

Cancer Immunotherapies Research Group receive prestigious travel awards

Dr Jake Gratten has joined Mater Research to head up the Cognitive Health Genomics group.

10

Sep

New researcher starting at Mater

Registrations are now open for the 2018 Mater Research Translating Research into Practice (TRIP) symposium, a full day event that will be held...

04

Sep

Registrations are now open for 2018 Mater Research Translating Research into Practice Symposium

Dr Shelley Wilkinson is a Senior Research Dietitian at the Mater Mothers' Hospital who is undertaking research to help women have healthier...

16

Aug

Pregnancy, nutrition and best practice

Prof John Hooper & his team are working towards improving the diagnosis & treatment of ovarian cancer by developing a unique PET imaging agent...

14

Aug

Increasing the visibility of cancer